Greenwich LifeSciences
GLSI
#8923
Rank
NZ$0.36 B
Marketcap
NZ$25.02
Share price
-7.90%
Change (1 day)
72.59%
Change (1 year)

Greenwich LifeSciences (GLSI) - P/B ratio

P/B ratio as of November 2026 : 64.8

According to Greenwich LifeSciences's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Greenwich LifeSciences - P/B ratio (from 2020 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-3120.236.49%
2022-12-3114.824.2%
2021-12-3111.9-28.89%
2020-12-3116.7
2019-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Organovo
ONVO
0.3500-99.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
4.74-92.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-6.97-110.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
3.91-93.97% Jersey